Q4 2013 Holdings
Filed 2014-02-14 | 26 holdings | $16.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $15.4M | 2,368,905 | 96.5% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $138.1K | 2,626,160 | 0.9% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $111.2K | 9,575,649 | 0.7% |
| Exelixis Inc | NOTE 4.250% 8/1 | 30161QAC8 | $50.1K | $40,735,000 | 0.3% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $45.1K | 7,796,516 | 0.3% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $37.8K | 7,553,089 | 0.2% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $32.2K | 1,090,478 | 0.2% |
| Targacept Inc | COM | 87611R306 | $25.6K | 6,171,669 | 0.2% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $22.6K | 7,943,215 | 0.1% |
| Oncothyreon Inc | COM | 682324108 | $15.8K | 9,001,778 | 0.1% |
| QLT Inc | COM | 746927102 | $13.2K | 2,370,263 | 0.1% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $12.5K | $12,000,000 | 0.1% |
| Receptos Inc | COM | 756207106 | $9.2K | 316,692 | 0.1% |
| Regado Biosciences Inc | COM | 75874Q107 | $7.9K | 1,659,091 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $7.7K | 461,000 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $7.5K | 820,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $6.1K | 2,824,387 | 0.0% |
| Palatin Technologies Inc | COM PAR $ .01 | 696077403 | $3.8K | 5,200,000 | 0.0% |
| Bind Therapeutics Inc | COM | 05548N107 | $2.3K | 150,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.2K | 134,317 | 0.0% |
| Sophiris BIO Inc | COM NEW | 83578Q209 | $2.2K | 600,000 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $1.7K | 233,689 | 0.0% |
| Kindred Biosciences Inc | COM | 494577109 | $577 | 51,788 | 0.0% |
| Transcept Pharmaceuticals in | COM | 89354M106 | $504 | 150,000 | 0.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $47 | 196,996 | 0.0% |
| Anthera Pharmaceuticals Inc | COM NEW | 03674U201 | $17 | 559,624 | 0.0% |